Sen­ate com­mit­tee punts on PBM re­form bill markup af­ter Re­pub­li­cans ques­tion process

While Sen­ate health com­mit­tee chair Bernie Sanders (I-VT) sought to race four new bills on PBM and FDA re­forms out of com­mit­tee to­day, Re­pub­li­cans ul­ti­mate­ly got their way af­ter com­plain­ing that the markup should ac­tu­al­ly fol­low next Wednes­day’s hear­ing with top in­sulin man­u­fac­tur­ers and PBM ex­ecs.

The change of plans to now mark up the new leg­is­la­tion next Thurs­day fol­lowed se­ri­ous process ques­tions from rank­ing mem­ber Bill Cas­sidy (R-LA), Sen. Mitt Rom­ney (R-UT) and oth­er Re­pub­li­cans as they com­plained that the process was out of or­der and that De­moc­rats had ac­cess to in­fo like CBO scores on the bills that Re­pub­li­cans had yet to see.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER